Funds with similar focus
|Arix Bioscience||England, London, United Kingdom|
|Centre for the Development of Industrial Technology (CDTI)||Madrid, Madrid, Spain|
|Coriant America||Chelmsford, Massachusetts, United States|
|Estlander & Partners||-|
|Formula Ventures||Israel, Tel Aviv, Tel Aviv District|
|Long Focus Capital||-|
|Modernization and Technology Development Fund||-|
|Mustedanagic & Plott Brothers GbR||-|
|North River Ventures||New York, New York, United States|
|Novozymes||Bagsværd, Denmark, Hovedstaden|
|Praktikerinvest||Stockholm, Stockholm County, Sweden|
|Taurus Ventures||California, San Francisco, United States|
|Tern||England, London, United Kingdom|
|The Foundry||California, Menlo Park, United States|
|Thermo Fisher Scientific||Massachusetts, United States, Waltham|
|UBS Asset Management||England, London, United Kingdom|
|Unicorn Capital Partners||China, Hong Kong, Hong Kong Island|
|VentureCrowd||Australia, New South Wales, Sydney|
|01 Jan 2020||Shanghai, Shanghai, China|
|01 Dec 2019||Beijing, Beijing, China|
|01 Jan 2019||Chengdu, Sichuan, China|
|01 Aug 2018||-|
|$463K||20 Mar 2018||Shanghai, China|
|01 Jan 2018||Wuxi, Anhui, China|
|$463K||26 Oct 2017||Qingyang District, Sichuan, China|
|29 Nov 2016||China, Beijing|
|$463K||23 Oct 2016||China, Haidian District|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.